TGTX - Financial Reports List - TG Therapeutics, Inc. - IntrinsicAlpha

TG Therapeutics, Inc. TGTX

Healthcare - Biotechnology - NASDAQ - US

$ 37.99

-3.52 %

$ 5.97 B

Market Cap

246.47

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	146.04%	261.84%	339.88%
Annual Report	FY	10-K	2024-12-31	40.80%	84.52%	103.21%
Quarterly Report	Q3	8-K	2024-09-30	-49.41%	-96.59%	-89.17%
Quarterly Report	Q2	8-K	2024-06-30	357.05%	114.45%	119.73%
Quarterly Report	Q1	8-K	2024-03-31	713.46%	72.28%	74.94%
Quarterly Report	Q4	8-K	2023-12-31	54863.75%	72.80%	76.02%
Annual Report	FY	10-K	2023-12-31	8290.02%	106.22%	110.70%
Quarterly Report	Q3	8-K	2023-09-30	176298.94%	410.66%	428.30%
Quarterly Report	Q2	8-K	2023-06-30	2606.06%	-13.14%	-14.72%
Quarterly Report	Q1	8-K	2023-03-31	287.05%	45.71%	44.68%

1